INTRODUCTION STATEMENT OF THE PROBLEM THE pharmaceutical market in India today is worth Rs.57206 crores up from Rs. 5000 crores in 1995*. It is one of the fastest growing markets with a growth rate of around 15%. India has a large number of Pharmaceutical companies which operate in an environment of high competition. The competition is even higher in a high generic market like in India where drugs are in fierce price competition. It is estimated that there are around 20‚000 pharmaceutical
Premium Physician Pharmacology Medicine
Introduction to the Indian Automobile Industry Starting its journey from the day when the first car rolled on the streets of Mumbai in 1898‚ the Indian automobile industry has demonstrated a phenomenal growth to this day. Today‚ the Indian automobile industry presents a galaxy of varieties and models meeting all possible expectations and globally established industry standards. Some of the leading names echoing in the Indian automobile industry include Maruti Suzuki‚ Tata Motors‚ Mahindra and Mahindra
Premium Tata Motors Automotive industry Suzuki
evade taxes by any chance v. Profit flies back to the home country 3. Define Subsidiary A unit plant or factory plant of the MNC that is usually located in LEDCs where costs are low (such as wages‚ land). 4. Why did N-Pharma open subsidiaries in Australia‚ Canada‚ Mexico‚ Chile‚ Vietnam‚ South Korea and New Zealand? i. Expansion for markets and proximity to the market ii. Vietnam‚
Premium Marketing Cash flow Stock market
ReporT ON Fundamental and technical analysis of icici bank Valuation-ICICI BANK Snapshot of ICICI Bank Market Capitalization: 101416 crores Free Float Factor : 1.0 52 week low : 641(NSE) 52 week High : 998.80(NSE) Performance of ICICI stock versus NSE Fundamental Analysis Macroeconomic Analysis Economic Indicators: 1. GDP Growth 2. Inflation 3. Liquidity 4. Interest Rate 5. SLR and CRR 6. Dollar Exchange Rate and Dollar Index
Premium P/E ratio Financial ratios Bank
The Fundamental Attribution Error(FAE) is when people do not factor in the person and the situation of what is happening (Stangor‚ Jhangiani & Tarry‚ 2014). The Department of Motor Vehicles(DMV) is the first case where I had observed the Fundamental Attribution Error. During this time‚ one of the workers was angry and acting mean from when it had looked like there was a sheet of paperwork missing from the stack. The paper in question had stuck to the paper in front of it due to how new the paper
Premium Management Project management Strategic management
growing rapidly due to the capability of Indian players to produce cost-effective drugs with world class manufacturing facilities. Bulk drugs of all major therapeutic groups‚ requiring complicated manufacturing processes are now being produced in India. Pharma companies have developed Good Manufacturing Practices (GMP) compliant facilities for the production of different dosage forms. In addition‚ India’s long-established position as a preferred manufacturing location for multinational drug manufacturers
Premium Pharmaceutical industry Clinical trial Pharmacology
Scenario ((Projected Pharmaceutical Market‚ 2004-2009)) 2.2.3 New Product Launches underlie market growth 2.2.5 Key Opportunities 2.2.6 FDI in Indian pharma 2.2.7 Strategy and Trends 2.2.8 Research and Development 2.2.9 SWOT Analysis 2.2.10 Mergers and Acquisitions in Pharma 2.2.11 Good Opportunities for ‘big pharma’ References Chapter Three-Merger between Glaxo Wellcome Smithkline Beecham 3.1 Introduction 3.2 Merger rationale 3.2.1 Rapid advances in Science
Premium Mergers and acquisitions Pharmaceutical industry
Big‚ Bad Pharma: An Unnecessary Evil Big‚ Bad Pharma: An Unnecessary Evil Big Pharma‚ or the pharmaceutical industry’s giant corporations‚ have earned record profits‚ falsified clinical trial data and corrupted the healthcare industry according to many industry critics including a recent report posted on Globalresearch.ca.[1] The industry’s story parallels the history of other corporate monopolies such as Big Oil‚ the Railroad Industry‚ Big Agriculture‚ banking interests and other industrial giants
Premium Pharmacology Clinical trial Medicine
FUNDAMENTAL ANALYSIS – POWER SECTOR SECURITY ANALYSIS AND PORTFOLIO MANAGEMENT SUBMITTED TO: PROF. HEMA BINDU KOTA SUBMITTED BY: BALJINDER SINGH 27113 NRIPENDRA SINGH 27067 NIKHIL VASU 27124 SHABAD KAPOOR 27007 SHILPA J 27074 SHRIKANT SHARMA 27134 VINIT GOGRI 27057 ECONOMIC ANALYSIS Introduction Economics experts and various studies conducted across the globe envisage
Premium Electricity generation Electric power transmission Nuclear power
MASTER OF BUSINESS ADMINISTRATION ASSIGNMENT SAIM ANALYSIS OF TATA MOTORS LTD. Submitted to: Submitted by: Ms. Richa MBA 3rd Semester Akanksha Jain(05817003909) Govind Singh Bisht(06917003909) SESSION: 2010 - 2011 TECNIA INSTITUTE OF ADVANCED STUDIES Approved by AICTE‚ Ministry of HRD‚ Govt. of India‚ Affiliated To Guru Gobind Singh Indraprastha University‚ Delhi INSTITUTIONAL AREA‚ MADHUBAN CHOWK‚ ROHINI
Premium Tata Motors